The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis

    NEXT STORY
    GigaGen to Present at the Inaugural LifeSci Partners Private Company Virtual Summer Symposium
    PREV STORY
    Smile Direct Club Now Serving Orthodontia’s Largest and Fastest-Growing Segment: Teens
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    INNATE PHARMA : Updated results that support advancement of IPH4102 in refractory Sézary syndrome at ASH 2018

    INNATE PHARMA ANNOUNCES UPDATED RESULTS THAT SUPPORT ADVANCEMENT OF IPH4102 IN REFRACTORY SÉZARY SYNDROME ...

    author_avatar
    NASDAQ Market News

    Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana

    First launch in Latin America Basel, Switzerland, March 06, 2018 - Basilea Pharmaceutica Ltd. ...

    author_avatar
    NASDAQ Market News

    Sports Medicine Market to Register a CAGR of 5.8% to Reach USD 9.86 billion by 2026; Escalating Innovation in New Products to Speed Up Growth Process, says Fortune Business Insights™

    author_avatar
    NASDAQ Market News